Joseph J. Campo
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$3.8MFederal grants as PI13 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
13 awards · $3.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 14, 2026 | NIH | SBIR Phase I Optimizing immunogenicity of novel Cryptosporidium vaccine candidates | $300K | — |
| Sep 9, 2026 | NIH | SBIR Phase I Identification of protective human monoclonal antibodies for passive immunization against Cryptosporidium | $300K | — |
| Aug 26, 2026 | NIH | SBIR Phase I Discovery of Group A Streptococcus antigens for development of broadly effective vaccine candidates to prevent non-invasive and invasive disease and emergence of antimicrobial resistance | $300K | — |
| Aug 6, 2026 | NIH | SBIR Phase I A sensitive and specific serology test for evaluating potency of whole cell Pertussis vaccines | $292K | — |
| Aug 25, 2025 | NIH | SBIR Phase I A sensitive and specific serology test for evaluating potency of whole cell Pertussis vaccines | $300K | — |
| Aug 12, 2025 | NIH | SBIR Phase I Optimizing immunogenicity of novel Cryptosporidium vaccine candidates | $300K | — |
| Apr 11, 2022 | NIH | SBIR Phase I Identification of bactericidal antibody specificities for the development of novel broad-coverage vaccine candidates against Neisseria meningitidis | $296K | — |
| May 12, 2021 | NIH | SBIR Phase I Identification of bactericidal antibody specificities for the development of novel broad-coverage vaccine candidates against Neisseria meningitidis | $300K | — |
| Mar 18, 2021 | NIH | SBIR Phase I Scanning the Cryptosporidium proteome for vaccine antigens | $300K | — |
| Dec 23, 2020 | NIH | SBIR Phase I Discovery of Treponema pallidum antigens for development of a sensitive and specific diagnostic test for syphilis | $300K | — |
| Mar 27, 2020 | NIH | SBIR Phase I Scanning the Cryptosporidium proteome for vaccine antigens | $300K | — |
| Dec 30, 2019 | NIH | SBIR Phase I Discovery of Treponema pallidum antigens for development of a sensitive and specific diagnostic test for syphilis | $300K | — |
| Mar 21, 2018 | NIH | SBIR Phase I Protective biomarkers for the development of novel serotype-independent protein-based vaccine candidates against pneumococcus | $225K | — |
Peer ranks
Federal funding#97
Awards as PI#30
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.